ArticleScientific reports2025
Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Substandard and falsified (SF) medicines pose a significant global health threat, particularly in regions experiencing socioeconomic instability. Lebanon’s multiple crises have increased vulnerability to counterfeit medications, positioning community pharmacists as crucial gatekeepers for medication safety. This study aimed to assess Lebanese community pharmacists’ knowledge, practices, and ability to detect counterfeit medications during the country’s ongoing, multifaceted crises and identify factors influencing their capacity to recognize SF medicines. A cross-sectional study was conducted between April and July 2024 using an anonymous, self-administered questionnaire among community pharmacists across Lebanon. Most pharmacists (84.2%) reported prior knowledge of counterfeit medicines and 54% had encountered such products. Despite relatively high knowledge scores (mean 7.69 ± 2.74), a critical gap was identified between theoretical knowledge and the practical ability to recognize counterfeit products assessed through picture-based identification of four commonly counterfeited medications, as indicated by the non-significant Pearson correlation between knowledge and recognition ability (r = 0.006, p = 0.864). Higher knowledge scores were significantly associated with non-smoking status (Standardized Beta (β)=-0.090, p = 0.010), verification of supplier credibility (β = 0.103, p = 0.004), belief in pharmacists’ role in combating counterfeits (β = 0.106, p = 0.003), and having previous knowledge on counterfeit medicines (β = 0.123, p < 0.001). However, these factors did not translate into enhanced recognition ability. This study reveals an alarming gap between Lebanese community pharmacists’ theoretical knowledge and practical recognition skills regarding counterfeit medicines. These findings highlight the urgent need for hands-on training programs and technological authentication tools to bridge the knowledge–recognition gap and strengthen pharmacists’ role as medication safety gatekeepers. A comprehensive national strategy should integrate practical counterfeit detection training into continuing education requirements, deploy digital authentication systems at points of dispensing, and establish real-time reporting platforms for suspected counterfeit incidents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.